Terumo Blood and Cell Technologies is committed to collaborating with visionaries to bring innovative technologies, devices and therapies to patients and the physicians who care for them. Our professionals in Strategic Growth & Alliances (SGA) play a critical role in the execution of our growth strategy and bring together teams with significant clinical, engineering, scientific, financial, commercial and business collaboration expertise. This ensures that our potential collaborators receive thoughtful evaluation and, once they are signed, expertly managed integration and execution.
With an unwavering commitment to unlocking the potential of blood and cells, we seek to collaborate with innovators who have developed disruptive or game-changing technologies in therapeutic apheresis, cell collections and regenerative medicine. In our desire to positively impact patients with blood cancers, autoimmune diseases and neurological disorders, we also seek novel nonpharmacological approaches to treat these conditions.
We welcome introductory discussions with organizations developing or marketing technologies or therapies in our patient focus areas. We will explore strategic alignment and collaboration opportunities ranging from distribution and comarketing to codevelopment in new ventures and new products. We are committed to best practices in corporate development, and our interactions will deliver clear communications, timely reviews and honest feedback.